Navigation Links
CSHL team perfects non-lethal way of switching off essential genes in mice
Date:4/14/2011

Cold Spring Harbor, N.Y. -- One way of discovering a gene's function is to switch it off and observe how the loss of its activity affects an organism. If a gene is essential for survival, however, then switching it off permanently will kill the organism before the gene's function can be determined. Researchers at Cold Spring Harbor Laboratory (CSHL) have overcome this problem by using RNA interference (RNAi) technology to temporarily turn off any essential gene in adult mice and then turn it back on before the change kills the animals.

In a study published online on April 12 in the journal Proceedings of the National Academy of Sciences, the scientists demonstrated the feasibility of this approach by turning off a gene necessary for DNA replication in mice until the animals lost weight and were at the brink of death, and then successfully reversing these symptoms and rescuing the mice by turning the gene back on.

The ability to regulate gene activity this way in animals "will not only help in pinpointing timeframes during which essential genes are important during development, but will also be tremendously useful in cancer or other disease-related research," says CSHL Professor and HHMI investigator Scott Lowe, Ph.D., who co-led the team along with Professor Bruce Stillman, Ph.D., CSHL's president. "We could, for example, first allow tumors to grow in mice, then shut off a gene that we think might be a good therapeutic target to test whether it saves the animals," Lowe explains.

To suppress gene activity with RNAi, scientists have been using short hairpin-shaped RNA (shRNA) molecules that attach to matching pieces of the target gene's RNA and trigger its destruction, thereby shutting down the production of protein from that gene. Having refined and optimized the process of using these shRNA to knock down gene activity in mice over the last few years, Lowe and collaborators including CSHL Professor and HHMI investigator Gregor
'/>"/>

Contact: Hema Bashyam
bashyam@cshl.edu
516-367-6822
Cold Spring Harbor Laboratory
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. New PerfectServe Clinician-to-Clinician Communications System Gives Physicians Control and Helps Hospitals Coordinate Care
2. Most patients stop drugs for essential tremor after deep brain stimulation surgery
3. Investigators discover enzyme essential for healthy lung development
4. Fuz is essential for craniofacial and tooth development
5. Lymph node dissection is not essential in small screen-detected lung cancers, new research shows
6. Early intervention essential to success for at-risk children: Queens University study
7. Immune systems bare essentials used to speedily detect drug targets
8. Newly discovered regulatory mechanism essential for embryo development and may contribute to cancer
9. Less than half of essential workers willing to report to work during a serious pandemic
10. Everyone Counts: Quality Data Essential to Improving People's Lives, Says UNFPA
11. Five Essential Steps to Choosing Toning Footwear
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CSHL team perfects non-lethal way of switching off essential genes in mice
(Date:8/1/2014)... -- Almost 140 people die every year in ... States. But there are several simple ways ... prevention coordinator at Cincinnati Children,s Hospital Medical Center,s ... center news release. "As families begin to ... for parents and children to go over school ...
(Date:8/1/2014)... Illinois (PRWEB) August 01, 2014 As ... across the country, Ronald E. Johnson, Jr. has been ... by AndroGel and other testosterone medications. Since the Fall ... Johnson, P.S.C. have worked diligently to investigate and prosecute ... pulmonary embolisms, and blood clots as a result of ...
(Date:8/1/2014)... August 01, 2014 Market Publishers ... reports have been added to its catalogue. ... Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services ... pharma industry drivers include, among others, increasing ageing ... hygiene. In 2015, the pharma market in India ...
(Date:8/1/2014)... HealthDay Reporter FRIDAY, Aug. 1, ... a time-honored destination for a good cut and conversation. ... be the spot to tackle an often overlooked health concern: ... partnership, the U.S. Centers for Disease Control and Prevention, together ... help of barbershop staff to both discuss and diagnose high ...
(Date:8/1/2014)... 2014 Over the past five ... innovative technologies that have enabled cosmetic dentists to ... color. Moreover, the burgeoning elderly population has stimulated ... ailments. Due to long-term use of medications, which ... demanded dental fillings, veneers and implants. As more ...
Breaking Medicine News(10 mins):Health News:Expert Offers School Bus Safety Tips 2Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 3Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 2Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 3Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... also available in Chinese ., , ... side effects of chemotherapy in cancer patients by stimulating ... in mice suggests., The research will appear in the ... which is published by AAAS, the nonprofit science ...
... A paper by Indiana University-Purdue University Indianapolis ... to improve identification of breast cancer tissue by ... scientific paper in the "bioinformatics and biomedical applications ... The best scientific paper award ...
... WEDNESDAY, Aug. 18 (HealthDay News) -- With their enticing cool ... the most controversial products made by the tobacco industry. ... of smokers aged 12 to 17 using menthol cigarettes, according ... Most black teenaged smokers -- and 82.7 percent of black ...
... Center in Israel have determined that the use ... outcome for patients undergoing percutaneous coronary intervention (PCI), ... appear in the September issue of Catheterization ... Wiley-Blackwell on behalf of The Society for Cardiovascular ...
... Aug. 19, 2010 A pediatric urologist at UT ... for young girls who have absent or malformed vaginas, ... Unknown causes and certain genetic disorders can cause ... other birth defects that can accompany the vaginal problems, ...
... To improve the quality of HIV care and treatment ... and monitoring of antiretroviral therapy should be adopted uniformly, according ... The work group,s study results appear in the current ... study shows how national HIV quality performance measures were developed, ...
Cached Medicine News:Health News:Ancient Chinese medicine may help chemotherapy patients 2Health News:FDA Mulling Ban on Menthol Cigarettes 2Health News:FDA Mulling Ban on Menthol Cigarettes 3Health News:FDA Mulling Ban on Menthol Cigarettes 4Health News:Drug-eluting stents confirmed safe, effective for long-term use 2Health News:Pediatric urologist performs innovative procedure for girls with rare vaginal defects 2Health News:Uniform, national measures should define HIV/AIDS care 2
(Date:7/31/2014)... Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) today ... June 30, 2014. Financial Results for the Six ... revenue for the quarter ended June 30, 2014 increased to ... 30, 2013 primarily due to IMBRUVICA ® (ibrutinib) net ... for the six months ended June 30, 2014 increased to ...
(Date:7/31/2014)... VIEW, Calif. , July 31, 2014 /PRNewswire/ ... today provided an update on its pipeline and ... 2014, Alexza expects to initiate a Phase 2a ... is being developed for the management of patients ... two new Staccato -based product candidates for ...
(Date:7/31/2014)... , July 31, 2014 Rock Creek Pharmaceuticals, ... it has initiated the development of its lead molecule, ... that it has selected Quotient Clinical, The Translational Pharmaceutics ... (UK) to run its early development programs. ... Application (CTA) by the end of the third quarter ...
Breaking Medicine Technology:Pharmacyclics Reports Second Quarter 2014 Results 2Pharmacyclics Reports Second Quarter 2014 Results 3Pharmacyclics Reports Second Quarter 2014 Results 4Pharmacyclics Reports Second Quarter 2014 Results 5Pharmacyclics Reports Second Quarter 2014 Results 6Pharmacyclics Reports Second Quarter 2014 Results 7Pharmacyclics Reports Second Quarter 2014 Results 8Pharmacyclics Reports Second Quarter 2014 Results 9Pharmacyclics Reports Second Quarter 2014 Results 10Pharmacyclics Reports Second Quarter 2014 Results 11Pharmacyclics Reports Second Quarter 2014 Results 12Pharmacyclics Reports Second Quarter 2014 Results 13Pharmacyclics Reports Second Quarter 2014 Results 14Pharmacyclics Reports Second Quarter 2014 Results 15Pharmacyclics Reports Second Quarter 2014 Results 16Pharmacyclics Reports Second Quarter 2014 Results 17Pharmacyclics Reports Second Quarter 2014 Results 18Pharmacyclics Reports Second Quarter 2014 Results 19Pharmacyclics Reports Second Quarter 2014 Results 20Pharmacyclics Reports Second Quarter 2014 Results 21Pharmacyclics Reports Second Quarter 2014 Results 22Pharmacyclics Reports Second Quarter 2014 Results 23Pharmacyclics Reports Second Quarter 2014 Results 24Pharmacyclics Reports Second Quarter 2014 Results 25Pharmacyclics Reports Second Quarter 2014 Results 26Pharmacyclics Reports Second Quarter 2014 Results 27Pharmacyclics Reports Second Quarter 2014 Results 28Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4
... March 30, 2011 Neurocrine Biosciences, Inc. (Nasdaq: ... Executive Officer of Neurocrine Biosciences, will be presenting at the ... The live presentation takes place on Wednesday, ... a.m. Pacific Time.  The presentation will be webcast and may ...
... 2011 CANTEL MEDICAL CORP. (NYSE: ... President, will be presenting at the Needham & Company, LLC ... 4:00 PM EDT on Wednesday, April 6, 2011 at the ... immediately following the presentation.  In addition, Mr. Segel will be ...
Cached Medicine Technology:
... Parathyroid hormone (PTH) is synthesized ... secreted in response to decreased extracellular ... enhancing bone resorption and decreasing calcium ... into the circulation, intact PTH is ...
... the adrenal cortex and, to a lesser ... a precursor in testosterone and estrogen synthesis, ... at ~10% that of testosterone [1]. However, ... women, DHEA is an important androgen as ...
... steroid, is one of the most potent ... testosterone is secreted primarily by the testes ... peripheral conversion of androstenedione [2]. In adult ... 50% of serum testosterone is derived from ...
... Thyroxine (T4) is the primary active ... the thyroid gland [1]. T4 is synthesized ... iodide trapping by the follicular cells, (ii) ... substrate leading to formation of 3-monoiodotyrosine and ...
Medicine Products: